American Financial Group’s Journey Medical DERM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.23M Hold
180,000
– – 0.43% 39
2026
Q2
$1.27M Hold
180,000
– – 0.45% 38
2026
Q1
$844K Hold
180,000
– – 0.31% 47
2025
Q4
$1.39M Hold
180,000
– – 0.5% 28
2025
Q3
$1.28M Hold
180,000
– – 0.49% 27
2025
Q2
$1.29M Hold
180,000
– – 0.48% 29
2025
Q1
$1.06M Hold
180,000
– – 0.45% 33
2024
Q4
$704K Hold
180,000
– – 0.32% 43
2024
Q3
$1.02M Hold
180,000
– – 0.44% 38
2024
Q2
$1.02M Hold
180,000
– – 0.44% 41
2024
Q1
$662K Hold
180,000
– – 0.25% 53
2023
Q4
$1.04M Hold
180,000
– – 0.38% 45
2023
Q3
$493K Hold
180,000
– – 0.17% 66
2023
Q2
$286K Hold
180,000
– – 0.09% 78
2023
Q1
$283K Hold
180,000
– – 0.09% 78
2022
Q4
$346K Hold
180,000
– – 0.12% 79
2022
Q3
$443K Hold
180,000
– – 0.15% 73
2022
Q2
$673K Hold
180,000
– – 0.23% 60
2022
Q1
$869K Hold
180,000
– – 0.26% 55
2021
Q4
$968K Buy
+180,000
New +$1.3M 0.27% 58

Other funds holding DERM

American Financial Group's DERM Position: Q3 2026 in Review

American Financial Group held its Journey Medical (DERM) position steady in Q3 2026 at 180,000 shares worth $1.23M. The position accounts for 0.43% of the portfolio, ranked #39.

American Financial Group first reported a position in DERM in Q4 2021 and has held it in 20 quarters since. The position peaked at $1.39M in Q4 2025. 74 funds tracked by Wall St. Rank hold DERM as of Q3 2026.

  • American Financial Group held 180,000 shares of Journey Medical worth $1.23M as of Q3 2026.
  • American Financial Group left its Journey Medical share count unchanged in Q3 2026.
  • Journey Medical made up 0.43% of American Financial Group's portfolio in Q3 2026, its #39 holding.
  • American Financial Group first reported a position in Journey Medical in Q4 2021 and has held it in 20 quarters since.
  • American Financial Group's Journey Medical position peaked at $1.39M in Q4 2025.
  • 74 funds tracked by Wall St. Rank held Journey Medical as of Q3 2026.

Based on American Financial Group's 13F filing for Q3 2026, filed 12 Nov 2026.